Google
ORMP — ORAMED PHARMACEUTICALS INC (Healthcare >> Biotechnology)
ORMP FAQ
What is ORMP's P/E ratio?
ORAMED PHARMACEUTICALS INC (ORMP) currently trades at a P/E ratio of 1.34.
What is ORMP's ROE?
ORAMED PHARMACEUTICALS INC reports a Return on Equity (ROE) of 46.17%.
What is ORMP's dividend yield?
ORAMED PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is ORMP's Deepscope Quality Score?
Deepscope rates ORMP's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ORMP?
Deepscope's AI Timing Score for ORMP is 69 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ORMP belong to?
ORAMED PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.60
Price
0.05
(1.39%)
Day Change
|
|
|---|
ORMP, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are ok , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
67% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 81 |
| Magic Formula Rank by ROA |
24
GREAT
|
| Magic Formula Rank by ROE |
24
GREAT
|
| Magic Formula Rank by ROIC |
42
GREAT
|
| Price | 3.60 |
| PBV / Sector |
0.62 / 4.53
GREAT
|
| Earning Per Share | 2.69 |
| PE / Sector |
1.34 / 16.80
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.51
|
| Average 1M Daily Value |
0.96 M
GREAT
|
| Average 1W Daily Value |
1.04 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-03 09:10:53 |
| Symbol | ORMP |
| Name | ORAMED PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 40.93 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 147.33 / 8,614.17 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1185 Avenue of the Americas, New York, NY, United States, 10036
Phone: 844 967 2633
Website: https://oramed.com
Sector: Healthcare >> Biotechnology
Description: Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
